Name | Value |
---|---|
Revenues | 24.3M |
Cost of Revenue | 17.4M |
Gross Profit | 6.8M |
Operating Expense | 73.3M |
Operating I/L | -32.5M |
Other Income/Expense | 24.4M |
Interest Income | 0.0M |
Pretax | -8.1M |
Income Tax Expense | 1.1M |
Net Income/Loss | -9.2M |
Recro Pharma, Inc. is a contract development and manufacturing organization specializing in the development, manufacturing, and packaging of therapeutic dosage forms, primarily in small molecule therapeutic development. The company offers a wide range of products including oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles. Additionally, it provides services in aseptic fill/finish, lyophilization, packaging, and logistics. Recro Pharma, Inc. generates revenue by providing these products and services to pharmaceutical companies for the development and production of various therapeutic medications.